Boca Raton Clinical Research (BRCR) Global

Clinical research site in Plantation, Florida · BRCR Global, 8200 W Sunrise Blvd # D2, Plantation, FL 33322 · (561) 447-0614 · Website

As of July 2026, 6 paid clinical trials are recruiting at Boca Raton Clinical Research (BRCR) Global in Plantation, Florida. Active studies at this site cover conditions such as Colorectal Cancer, Gastric Cancer and Gastroesophageal-junction Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Boca Raton Clinical Research (BRCR) Global (6)

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for Gastroesophageal-junction Cancer

29 locations incl. Anaheim

Sponsor: Shanghai Henlius Biotech

Sex: All·Age: 18+

Code: NCT06532006·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

19 locations incl. Anchorage

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06899126·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

for Breast Cancer

22 locations incl. Duarte

Sponsor: Celcuity Inc

Sex: All·Age: 18+

Code: NCT06757634·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

for Relapsed/Refractory Follicular Lymphoma

7 locations incl. Los Angeles

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06149286·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies

for Mature B-cell Malignancies

2 locations incl. Plantation

Sponsor: InnoCare Pharma Inc.

Sex: All·Age: 18+

Code: NCT06351527·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

A Study of IBI363 in Subjects with Advanced Solid Malignancies

for Melanoma

9 locations incl. San Francisco

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All·Age: 18+

Code: NCT06281678·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

More research sites in Plantation

UM Sylvester Comprehensive Cancer Center at Plantation (40 trials)
BRCR Global (10 trials)
Florida Clinical Trials Group (5 trials)
Integral Rheumatology And Immunology Specialists (4 trials)
BRCR Medical Center (3 trials)
IRIS Research and Development (3 trials)
Miami Cancer Institute at Plantation (3 trials)
Clinical Study Site (2 trials)
BRCR Medical Center Inc (2 trials)
Florida Clinical Trials Group LLC (Plantation) (2 trials)

Explore more

Paid clinical trials in Plantation, FL · Florida clinical trials